Michael Zinda

EVP, Chief Science Officer, Repare Therapeutics Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 12, 2025Sold 5,611 shares at $1.14 of Repare Therapeutics Inc.²
Mar 4, 2025Granted 14,000 shares of Repare Therapeutics Inc.³
Apr 1, 2024Sold 410 shares at $4.66 of Repare Therapeutics Inc.⁴
Mar 28, 2024Sold 450 shares at $4.64 of Repare Therapeutics Inc.⁴
Mar 27, 2024Sold 450 shares at $4.62 of Repare Therapeutics Inc.⁵
Mar 26, 2024Sold 450 shares at $4.61 of Repare Therapeutics Inc.⁵
Mar 25, 2024Sold 450 shares at $4.78 of Repare Therapeutics Inc.⁵
Mar 1, 2024Granted 14,000 shares of Repare Therapeutics Inc.⁶
Jun 8, 2023Sold 2,869 shares at $12.02 of Repare Therapeutics Inc.⁷
Jun 7, 2023Sold 6,404 shares at $12.03 of Repare Therapeutics Inc.⁷
Jun 6, 2023Sold 1,200 shares at $12.04 of Repare Therapeutics Inc.⁸
Jan 30, 2023Granted 24,550 shares of Repare Therapeutics Inc.⁹
Mar 15, 2022Sold 533 shares at $11.30 of Repare Therapeutics Inc.¹⁰
Nov 23, 2021Exercised options 10,473 shares at $2.43 of Repare Therapeutics Inc.¹¹
Nov 23, 2021Exercised options 19,590 shares at $2.06 of Repare Therapeutics Inc.¹¹
Nov 23, 2021Exercised options 11,856 shares at $1.64 of Repare Therapeutics Inc.¹¹
Nov 23, 2021Exercised options 4,122 shares at $1.64 of Repare Therapeutics Inc.¹¹
Nov 15, 2021Sold 3,900 shares at $27.87 of Repare Therapeutics Inc.¹²
Nov 15, 2021Sold 16,100 shares at $27.20 of Repare Therapeutics Inc.¹²

The numbers on this page point here. Each one links to the record it came from.